New hope for kids with severe epilepsy: groundbreaking trial targets root cause
Disease control
Recruiting now
This study is testing an investigational medicine called zorevunersen (STK-001) for children and adolescents with Dravet syndrome, a severe form of epilepsy. The goal is to see if the medicine can safely reduce the number of major seizures and improve behavior, thinking, and qual…
Phase: PHASE3 • Sponsor: Stoke Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC